Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease <i>via</i> necroptosis-independent pathway.

World J Gastroenterol · 2025 · PMC11752702 · PMID 39958438

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

According to the biochemical analysis of serum AST and ALT, CPD4-treated mice showed a decreasing trend, although this difference was not statistically significant (Figure 6D and E ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease &lt;i&gt;via&lt;/i&gt; necroptosis-independent pathway.

The sentences

Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease <i>via</i> necroptosis-independent pathway.